Re: Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al. Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 2023;83:145-51

被引：0
|
作者：
Li, Jinze [1 ,2 ]
Chen, Bo [1 ,2 ]
Cao, Dehong [1 ,3 ]
机构：
[1] Sichuan Univ, West China Hosp, Inst Urol, Dept Urol, Chengdu, Peoples R China
[2] Sichuan Univ, West China Sch Clin Med, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, Inst Urol, Dept Urol, 37 Guoxue Rd, Chengdu 610041, Sichuan, Peoples R China
来源：
UROLOGY | 2023年 / 84卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E75 / E75
页数：1
相关论文
共 27 条
  • [1] Re: Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al. Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Li, Jinze
    Chen, Bo
    Cao, Dehong
    [J]. EUROPEAN UROLOGY, 2023, 84 (03) : E75 - E75
  • [2] Re: Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
    Liu, Jianliang
    Moon, Daniel
    Lawrentschuk, Nathan
    [J]. EUROPEAN UROLOGY, 2023, 84 (02) : 244 - 245
  • [3] Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
    Bakouny, Ziad
    El Zarif, Talal
    Dudani, Shaan
    Wells, J. Connor
    Gan, Chun Loo
    Donskov, Frede
    Shapiro, Julia
    Davis, Ian D.
    Parnis, Francis
    Ravi, Praful
    Steinharter, John A.
    Agarwal, Neeraj
    Alva, Ajjai
    Wood, Lori
    Kapoor, Anil
    Morales, Jose M. Ruiz
    Kollmannsberger, Christian
    Beuselinck, Benoit
    Xie, Wanling
    Heng, Daniel Y. C.
    Choueiri, Toni K.
    [J]. EUROPEAN UROLOGY, 2023, 83 (02) : 145 - 151
  • [4] Re: Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study From the International Metastatic Renal Cell Carcinoma Database Consortium Editorial Comment
    Laguna, M. Pilar
    [J]. JOURNAL OF UROLOGY, 2023, 210 (03): : 562 - 564
  • [5] Prognostic model of upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors and/or targeted agents
    Teishima, Jun
    Goto, Keisuke
    Sekino, Yohei
    Mita, Koji
    Hayashi, Tetsutaro
    Hasegawa, Yasuhisa
    Kato, Masao
    Kajiwara, Mitsuru
    Shigeta, Masanobu
    Maruyama, Satoshi
    Kadonishi, Yuichi
    Fujiwara, Seiji
    Kobayashi, Kanao
    Asano, Kousuke
    Hinata, Nobuyuki
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (06) : 1225 - 1232
  • [6] Prognostic model of upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors and/or targeted agents
    Jun Teishima
    Keisuke Goto
    Yohei Sekino
    Koji Mita
    Tetsutaro Hayashi
    Yasuhisa Hasegawa
    Masao Kato
    Mitsuru Kajiwara
    Masanobu Shigeta
    Satoshi Maruyama
    Yuichi Kadonishi
    Seiji Fujiwara
    Kanao Kobayashi
    Kousuke Asano
    Nobuyuki Hinata
    [J]. International Urology and Nephrology, 2022, 54 : 1225 - 1232
  • [7] Re: Kosuke Takemura, Matthew S. Ernst, Vishal Navani, et al. Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol Oncol.
    Ishiyama, Yudai
    Urabe, Fumihiko
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 642 - 643
  • [8] Cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) or targeted therapy (TT): A propensity score-based analysis
    Bakouny, Ziad
    Xie, Wanling
    Dudani, Shaan
    Wells, Connor
    Gan, Chun Loo
    Donskov, Frede
    Shapiro, Julia
    Davis, Ian D.
    Parnis, Francis
    Ravi, Praful
    Steinharter, John A.
    Agarwal, Neeraj
    Alva, Ajjai Shivaram
    Wood, Lori
    Kapoor, Anil
    Morales, Jose Manuel Ruiz
    Kollmannsberger, Christian K.
    Beuselinck, Benoit
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [9] Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol 2023;84:109-16
    Saal, Jonas
    Gruenwald, Viktor
    Kluemper, Niklas
    [J]. EUROPEAN UROLOGY, 2023, 84 (06) : E143 - E144
  • [10] Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84: 109-116
    Zhao, Binghao
    Xing, Hao
    Ma, Wenbin
    [J]. EUROPEAN UROLOGY, 2023, 84 (01) : E16 - E17
123